Natural Killer Cell Therapy Market Size (USD 5175.3 M) by 2032 By Type (NK Cell Therapies, NK Cell Directed Antibodies), By Applications Covered (Cancer, Gastrointestinal Diseases, Other) and Regional Forecast to 2032

Detailed TOC of Global Natural Killer Cell Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2031

Table of Content

1 Natural Killer Cell Therapy Market Overview
1.1 Product Overview and Scope of Natural Killer Cell Therapy Market
1.2 Natural Killer Cell Therapy Market Segment by Type
1.2.1 Global Natural Killer Cell Therapy Market Sales Volume and CAGR (%) Comparison by Type (2017-2031)
1.3 Global Natural Killer Cell Therapy Market Segment by Application
1.3.1 Natural Killer Cell Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2031)
1.4 Global Natural Killer Cell Therapy Market, Region Wise (2017-2031)
1.4.1 Global Natural Killer Cell Therapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2031)
1.4.2 United States Natural Killer Cell Therapy Market Status and Prospect (2017-2031)
1.4.3 Europe Natural Killer Cell Therapy Market Status and Prospect (2017-2031)
1.4.4 China Natural Killer Cell Therapy Market Status and Prospect (2017-2031)
1.4.5 Japan Natural Killer Cell Therapy Market Status and Prospect (2017-2031)
1.4.6 India Natural Killer Cell Therapy Market Status and Prospect (2017-2031)
1.4.7 Southeast Asia Natural Killer Cell Therapy Market Status and Prospect (2017-2031)
1.4.8 Latin America Natural Killer Cell Therapy Market Status and Prospect (2017-2031)
1.4.9 Middle East and Africa Natural Killer Cell Therapy Market Status and Prospect (2017-2031)
1.5 Global Market Size of Natural Killer Cell Therapy (2017-2031)
1.5.1 Global Natural Killer Cell Therapy Market Revenue Status and Outlook (2017-2031)
1.5.2 Global Natural Killer Cell Therapy Market Sales Volume Status and Outlook (2017-2031)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Natural Killer Cell Therapy Market

2 Industry Outlook
2.1 Natural Killer Cell Therapy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Natural Killer Cell Therapy Market Drivers Analysis
2.4 Natural Killer Cell Therapy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Natural Killer Cell Therapy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Natural Killer Cell Therapy Industry Development

3 Global Natural Killer Cell Therapy Market Landscape by Player
3.1 Global Natural Killer Cell Therapy Sales Volume and Share by Player (2017-2022)
3.2 Global Natural Killer Cell Therapy Revenue and Market Share by Player (2017-2022)
3.3 Global Natural Killer Cell Therapy Average Price by Player (2017-2022)
3.4 Global Natural Killer Cell Therapy Gross Margin by Player (2017-2022)
3.5 Natural Killer Cell Therapy Market Competitive Situation and Trends
3.5.1 Natural Killer Cell Therapy Market Concentration Rate
3.5.2 Natural Killer Cell Therapy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion

4 Global Natural Killer Cell Therapy Sales Volume and Revenue Region Wise (2017-2022)
4.1 Global Natural Killer Cell Therapy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Natural Killer Cell Therapy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Natural Killer Cell Therapy Market Under COVID-19
4.5 Europe Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Natural Killer Cell Therapy Market Under COVID-19
4.6 China Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Natural Killer Cell Therapy Market Under COVID-19
4.7 Japan Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Natural Killer Cell Therapy Market Under COVID-19
4.8 India Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Natural Killer Cell Therapy Market Under COVID-19
4.9 Southeast Asia Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Natural Killer Cell Therapy Market Under COVID-19
4.10 Latin America Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Natural Killer Cell Therapy Market Under COVID-19
4.11 Middle East and Africa Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Natural Killer Cell Therapy Market Under COVID-19

5 Global Natural Killer Cell Therapy Sales Volume, Revenue, Price Trend by Type
5.1 Global Natural Killer Cell Therapy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Natural Killer Cell Therapy Revenue and Market Share by Type (2017-2022)
5.3 Global Natural Killer Cell Therapy Price by Type (2017-2022)
5.4 Global Natural Killer Cell Therapy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Natural Killer Cell Therapy Sales Volume, Revenue and Growth Rate of NK Cell Therapies (2017-2022)
5.4.2 Global Natural Killer Cell Therapy Sales Volume, Revenue and Growth Rate of NK Cell Directed Antibodies (2017-2022)

6 Global Natural Killer Cell Therapy Market Analysis by Application
6.1 Global Natural Killer Cell Therapy Consumption and Market Share by Application (2017-2022)
6.2 Global Natural Killer Cell Therapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Natural Killer Cell Therapy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Natural Killer Cell Therapy Consumption and Growth Rate of Cancer (2017-2022)
6.3.2 Global Natural Killer Cell Therapy Consumption and Growth Rate of Gastrointestinal Diseases (2017-2022)
6.3.3 Global Natural Killer Cell Therapy Consumption and Growth Rate of Other (2017-2022)

7 Global Natural Killer Cell Therapy Market Forecast (2022-2031)
7.1 Global Natural Killer Cell Therapy Sales Volume, Revenue Forecast (2022-2031)
7.1.1 Global Natural Killer Cell Therapy Sales Volume and Growth Rate Forecast (2022-2031)
7.1.2 Global Natural Killer Cell Therapy Revenue and Growth Rate Forecast (2022-2031)
7.1.3 Global Natural Killer Cell Therapy Price and Trend Forecast (2022-2031)
7.2 Global Natural Killer Cell Therapy Sales Volume and Revenue Forecast, Region Wise (2022-2031)
7.2.1 United States Natural Killer Cell Therapy Sales Volume and Revenue Forecast (2022-2031)
7.2.2 Europe Natural Killer Cell Therapy Sales Volume and Revenue Forecast (2022-2031)
7.2.3 China Natural Killer Cell Therapy Sales Volume and Revenue Forecast (2022-2031)
7.2.4 Japan Natural Killer Cell Therapy Sales Volume and Revenue Forecast (2022-2031)
7.2.5 India Natural Killer Cell Therapy Sales Volume and Revenue Forecast (2022-2031)
7.2.6 Southeast Asia Natural Killer Cell Therapy Sales Volume and Revenue Forecast (2022-2031)
7.2.7 Latin America Natural Killer Cell Therapy Sales Volume and Revenue Forecast (2022-2031)
7.2.8 Middle East and Africa Natural Killer Cell Therapy Sales Volume and Revenue Forecast (2022-2031)
7.3 Global Natural Killer Cell Therapy Sales Volume, Revenue and Price Forecast by Type (2022-2031)
7.3.1 Global Natural Killer Cell Therapy Revenue and Growth Rate of NK Cell Therapies (2022-2031)
7.3.2 Global Natural Killer Cell Therapy Revenue and Growth Rate of NK Cell Directed Antibodies (2022-2031)
7.4 Global Natural Killer Cell Therapy Consumption Forecast by Application (2022-2031)
7.4.1 Global Natural Killer Cell Therapy Consumption Value and Growth Rate of Cancer(2022-2031)
7.4.2 Global Natural Killer Cell Therapy Consumption Value and Growth Rate of Gastrointestinal Diseases(2022-2031)
7.4.3 Global Natural Killer Cell Therapy Consumption Value and Growth Rate of Other(2022-2031)
7.5 Natural Killer Cell Therapy Market Forecast Under COVID-19

8 Natural Killer Cell Therapy Market Upstream and Downstream Analysis
8.1 Natural Killer Cell Therapy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Natural Killer Cell Therapy Analysis
8.6 Major Downstream Buyers of Natural Killer Cell Therapy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Natural Killer Cell Therapy Industry

9 Players Profiles
9.1 Glycostem Therapeutics BV
9.1.1 Glycostem Therapeutics BV Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Natural Killer Cell Therapy Product Profiles, Application and Specification
9.1.3 Glycostem Therapeutics BV Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Nkarta Therapeutics, Inc.
9.2.1 Nkarta Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Natural Killer Cell Therapy Product Profiles, Application and Specification
9.2.3 Nkarta Therapeutics, Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Fate Therapeutics
9.3.1 Fate Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Natural Killer Cell Therapy Product Profiles, Application and Specification
9.3.3 Fate Therapeutics Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Fortress Biotech
9.4.1 Fortress Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Natural Killer Cell Therapy Product Profiles, Application and Specification
9.4.3 Fortress Biotech Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Affimed N.V.
9.5.1 Affimed N.V. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Natural Killer Cell Therapy Product Profiles, Application and Specification
9.5.3 Affimed N.V. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Celgene Corporation
9.6.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Natural Killer Cell Therapy Product Profiles, Application and Specification
9.6.3 Celgene Corporation Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Nantkwest Inc.
9.7.1 Nantkwest Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Natural Killer Cell Therapy Product Profiles, Application and Specification
9.7.3 Nantkwest Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 NKT Therapeutics Inc.
9.8.1 NKT Therapeutics Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Natural Killer Cell Therapy Product Profiles, Application and Specification
9.8.3 NKT Therapeutics Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Ziopharm Oncology Inc.
9.9.1 Ziopharm Oncology Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Natural Killer Cell Therapy Product Profiles, Application and Specification
9.9.3 Ziopharm Oncology Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Innate Pharma S.A.
9.10.1 Innate Pharma S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Natural Killer Cell Therapy Product Profiles, Application and Specification
9.10.3 Innate Pharma S.A. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source